
Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …

The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according …

French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal …

The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …

Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …

The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and …

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …

The American multinational GE Healthcare is opening a 27,000-sq-ft innovation centre in Uppsala, Sweden in an effort to boost the …

Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …

Chinese Premier Li Keqiang has spoken out against drug maker Changsheng Biotechnology after the Chinese firm was found to have …

Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that …

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …

Going from the youngest female self-made billionaire in the world to being charged with engaging in schemes to defraud investors …

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …